Compounded weight-loss medications, such as those promoted in the Hims & Hers commercial, aren’t approved by the Food and Drug Administration.

Novo Nordisk's 2024 earnings exceeded estimates, with strong performance in diabetes, obesity, and rare disease segments.

The case for GLP-1 drugs like Ozempic possibly causing blindness is building. A new paper out this week describes several ...

Symptoms of NAION can include blurred vision, peripheral vision loss, dark spots in vision, and changes in color perception. Though the exact mechanism is not fully understood, researchers hypothesize ...

A new review reports that nine people taking semaglutide and tirzepatide — the active ingredient in GLP-1 medications — experienced vision issues, including three potentially blinding eye conditions.

If it’s related to blood sugar management, they may change your diabetes treatment plan. If it’s not, your doctor will check for other causes and discuss treatment options with you.

Ozempic is a GLP-1 receptor agonist, a type of medication that mimics a hormone involved in regulating blood sugar and appetite. It slows digestion, increases insulin production, and reduces ...

Ozempic has gained widespread recognition in ... Dual forms of Chromium (Picolinate & Nicotinate Glycinate Chelate) to stabilize blood sugar and curb cravings. L-Carnitine L-Tartrate facilitates ...

A new study adds to a growing body of research suggesting a potential link between popular GLP-1 medications like Ozempic and vision loss.

There are no studies documenting the percentage of doctors taking the drugs. But physicians “are a good litmus test for drugs ...

The blockbuster drug semaglutide, better known as Ozempic for diabetes and Wegovy for obesity, could also help people cut ...